Olorinab
Olorinab (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist, with an EC50 of 6.2 nM for hCB2.
Product Specifications
CAS Number
1268881-20-4
Product Name Alternative
APD 371
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/APD_371.html
Purity
99.29
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(C1=NN(C2=C[N+]([O-])=CC=N2)C3=C1C[C@@]4([H])[C@]3([H])C4)N[C@H](CO)C(C)(C)C
Molecular Formula
C18H23N5O3
Molecular Weight
357.41
References & Citations
[1]Han S, et al. Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain. ACS Med Chem Lett. 2017 Nov 30;8 (12) :1309-1313.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY428294 100 µg
TropomoduLin 2 (TMOD2) (NM_001142885) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC401597-100 1x 100 µL
IL-4 / Interleukin 4 (IL4/1597), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details